AURORA Study-A Transformative Approach to Support PrEP Medication Persistence

Part of paid clinical trials in Charleston, West Virginia.

Sponsor
WV Health Right, Inc.
Study ID
NCT06072443
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Digital Health Companion (mobile App) — BEHAVIORAL
    Participants will complete education modules, health literacy evaluations, and PRO assessments in the Digital Health Companion.

Study Details

This study is designed to test the hypothesis that, compared to oral PrEP, use of CAB-LA in underserved populations in a real-world setting supported by a digital health companion program will be associated with greater medication adherence, persistence, retention-in-care, and improved PROs. Patients in the study will receive current standard care for HIV prevention and be offered enrollment in the digital health companion program. Goal of the study is to evaluate medication adherence and persistence in patients receiving CAB-LA vs oral PrEP and who engage with a digital health companion program.

Key Dates

Start date
Nov 30, 2023
Status verified
Jun 2024
Primary completion
Dec 30, 2024
Completion
Jun 30, 2025

Study Design

Enrollment
105 participants (estimated)

Arms

  • Arm: CAB-LA PrEP Cohort
    Prescribed CAB-LA PrEP as standard of care or current user of CAB-LA PrEP
  • Arm: Oral PrEP Cohort
    Prescribed oral PrEP as standard of care or current user of oral PrEP

Primary Outcome Measure

EFFICACY: Medication Adherence [ Time Frame: 12-months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
West Virginia Health RightCharlestonWest Virginia25311
Rhonda Francis
305-414-5930

Find similar trials in Charleston, WV

By condition
HIV
By specialty
Infectious disease
By research site
West Virginia Health Right· Charleston, WV

Related Studies